https://www.selleckchem.com/pr....oducts/nutlin-3a.htm
multiple conditions, reduced health and affective status, independently from other patients' characteristics. Careful attention about indication, benefit and potential risk should be paid especially to patients on therapy with specific drug classes identified as potentially inappropriate or prone to major DDIs in older persons (e.g., benzodiazepines, NSAIDs, protonic pump inhibitors, antithrombotics/anticoagulants, antidepressants/antipsychotics). The cluster-RCT on which this cross-sectional analysis is based was registered with Curr
Like
Comment
Share
